Msbio
1 known investors
MS BIO develops products for the treatment and regeneration of damaged tissue using human tissue and biomaterials such as collagen. It works with clinical experts and corporate partners to research and develop these regenerative medicine products.
Also known as MS BIO · MS BIO, Inc. · 엠에스바이오
Investors · 1
Company profile
researched Aug 2026MS BIO, Inc. (엠에스바이오) is a South Korea–based company that researches and develops products intended for the treatment and regeneration of damaged tissue, using human tissue and biomaterials such as collagen. The company positions itself around creating value through people, working with networks of clinical experts and corporate partners to generate ideas and realize them through product development aimed at patient health.
The company organizes its offering into allograft tissue and medical device product lines. Its listed medical device products include MYGEN, described as a low-antigenicity collagen injector; MS Hydrolifting; MS Collagen, a low-antigenicity atelocollagen; and MYGIS, a resorbable collagen membrane for guided bone regeneration (GBR).
Business model
MS BIO develops and supplies products derived from human tissue and biomaterials, spanning allograft tissue and medical devices such as collagen injectors, atelocollagen and resorbable collagen membranes.
▸Full profile — technology, go-to-market, geography
Technology
The company's work centers on human tissue and biomaterials, particularly collagen. Product descriptions reference low-antigenicity collagen and atelocollagen formulations and a resorbable collagen membrane for guided bone regeneration.
Go-to-market
The company states it develops ideas and products together with networks of clinical experts and corporate partners.
Geography
Headquartered in South Korea; the company website is published in Korean and English.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 5
primary sources listed
- Msbiomsbio.co.kr · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Msbio do?
- Korean company researching human tissue and collagen-based products for treating and regenerating damaged tissue.
- Who are Msbio's investors?
- Msbio's investors include Kiwoom Investment.